Petros Pharmaceuticals Inc. (PTPI) Social Stream
PETROS PHARMACEUTICALS INC (PTPI) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering PETROS PHARMACEUTICALS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-12-08 | 1 | $4 | $4 | $4 | $1.33 | 200.75% |
| NA | 1 | $NA | $NA | $NA | $1.33 | NA% |
Price Target Last Issued December 8, 2023
PTPI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, PETROS PHARMACEUTICALS INC's number of analysts covering the stock is higher than just about none of of them.
- PTPI has a lower variance in analysts' estimates than just about 100% of all US stocks.
- In the context of Healthcare stocks, PETROS PHARMACEUTICALS INC's average analyst price target is greater than 4.38% of them.
- PETROS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 31.61% of stocks in the nano market cap category.
Stocks similar to PETROS PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GRI, RNAZ, and UNCY.
View All Top Stocks by Price Target
Is PTPI a Buy, Hold or Sell? See the POWR Ratings now!